erlotinib hydrochloride has been researched along with clodronic acid in 1 studies
| Studies (erlotinib hydrochloride) | Trials (erlotinib hydrochloride) | Recent Studies (post-2010) (erlotinib hydrochloride) | Studies (clodronic acid) | Trials (clodronic acid) | Recent Studies (post-2010) (clodronic acid) |
|---|---|---|---|---|---|
| 4,353 | 786 | 3,033 | 1,748 | 210 | 477 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berry, G; Burt, BM; Engleman, E; Kheradmand, F; Lee, HS; Sugarbaker, DJ; Wang, DH; Wheeler, TM; Yoon, D | 1 |
1 other study(ies) available for erlotinib hydrochloride and clodronic acid
| Article | Year |
|---|---|
Progression of EGFR-Mutant Lung Adenocarcinoma is Driven By Alveolar Macrophages.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents, Immunological; Cetuximab; Clodronic Acid; Cytokines; Disease Progression; Drug Resistance, Neoplasm; ErbB Receptors; Erlotinib Hydrochloride; Female; Gene Expression Regulation, Neoplastic; Genes, erbB-1; Genes, Synthetic; Humans; Lung Neoplasms; Macrophage Activation; Macrophages, Alveolar; Mice; Mice, Transgenic; Neoplasm Proteins; Oligonucleotide Array Sequence Analysis; Protein Kinase Inhibitors; Recombinant Fusion Proteins; Smoking; Uteroglobin | 2017 |